https://elevagemedical.com/elucid-raises-80-million-in-series-c-round-led-by-elevage-medical-technologies/2024-10-29T04:44:42+00:00https://elevagemedical.com/elevage-medical-technologies-continues-expansion-of-investment-team-and-board/2024-10-29T04:44:34+00:00https://elevagemedical.com/patient-square-capital-announces-formation-of-elevage-medical-technologies-to-partner-with-growth-stage-medical-device-companies/2024-10-29T04:44:45+00:00https://elevagemedical.com/nuclera-closes-75-million-usd-financing/2024-11-19T07:54:23+00:00https://elevagemedical.com/moximed-completes-closing-of-series-d-financing-for-91-million-to-accelerate-commercialization-of-misha-knee-system-an-implantable-shock-absorber-for-knee-osteoarthritis/2024-11-19T07:55:05+00:00https://elevagemedical.com/4basebio-plc-completion-of-strategic-investment/2024-12-28T10:26:55+00:00https://elevagemedical.com/fire1-secures-120-million-financing-to-revolutionize-heart-failure-care/2025-01-10T06:31:50+00:00https://elevagemedical.com/setpoint-medical-raises-140-million-in-private-financing-and-expands-leadership-team-to-support-commercialization-of-rheumatoid-arthritis-therapy/2025-08-13T08:46:02+00:00https://elevagemedical.com/new-implant-offers-hope-foreasing-rheumatoid-arthritis/2025-08-27T08:51:04+00:00https://elevagemedical.com/galvanize-therapeutics-raises-100-million-in-oversubscribed-series-c-financing-to-transform-the-treatment-of-cancer-and-chronic-lung-disease/2025-09-06T05:40:06+00:00https://elevagemedical.com/setpoint-system-an-implant-to-treat-an-autoimmune-disease/2025-10-17T07:30:37+00:00https://elevagemedical.com/biobeat-secures-50-million-series-b-financing-to-advance-commercialization-of-its-patch-worn-cuff-less-24-hour-ambulatory-blood-pressure-monitor/2026-01-07T11:57:44+00:00https://elevagemedical.com/arthroscopy-association-of-north-america-advocacy-helps-expand-access-for-innovative-orthopedic-treatment/2026-02-20T05:03:17+00:00https://elevagemedical.com/imperative-care-announces-100-million-financing/2026-03-19T04:23:44+00:00